// App-Quantinova.ai

: Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients with Resected Ampullary Adenocarcinoma

Researchers

Presenter

  • D.H. Lemmers

Principal Investigators

  • S. Robinson

  • M. Bonds

  • M. Mortimer

  • V.K. Mavroeidis

  • F. Burdio

  • L. Bolm

  • P. Pessaux

  • U. Wellner

  • B. Ielpo

  • Z. Soonawalla

  • B. Al-Sarireh

  • T. Armstrong

  • A. Alseidi

  • S. White

  • A. Zerbi

  • M.G. Besselink

  • M. Abu Hilal

Medical Centers

  • University Medical Center Schleswig-Holstein, Campus Lübeck, Surgery, Lübeck, Germany

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

  • Humanitas Research Hospital, Pancreatic Surgery Unit, Surgery, Rozzano, Italy

  • Fondazione Poliambulanza, Brescia, Italy

  • Morriston Hospital, Surgery, Swansea, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Nouvel Hôpital Civil (NHC), Hepatobiliary and Pancreatic Surgical Unit, Surgery, Strasbourg, France

  • Virginia Mason Medical Center, Surgery, Seattle, United States

  • Oxford University Hospitals NHS Foundation Trust, Department of Hepatobiliary and Pancreatic Surgery, Oxford, United Kingdom

  • Hospital del Mar, Hepatopancreatobiliary Unit, Surgery, Barcelona, Spain

  • Amsterdam UMC, Cancer Center, University of Amsterdam, Surgery, Amsterdam, Netherlands

Locations

  • Germany

  • France

  • United Kingdom

  • United States

  • Italy

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ampullary adenocarcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved